AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 283: F68-F72, 2002. First published February 12, 2002; doi:10.1152/ajprenal.00364.2001
0363-6127/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/F68    most recent
00364.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beierwaltes, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beierwaltes, W. H.
Vol. 283, Issue 1, F68-F72, July 2002

Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion

William H. Beierwaltes

Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Michigan 48202-2689

Cyclooxygenase (COX)-2 is in the macula densa, cosegregating with neuronal nitric oxide synthase (nNOS). It is hypothesized that in response to acute inhibition of NOS, the influence of COX-2-derived prostanoids is exaggerated, compensating for renal vasoconstriction. Blood pressure (BP) and renal blood flow (RBF) were measured after selective COX-2 inhibition with NS-398 followed by NOS inhibition with L-nitro arginine methyl ester (L-NAME) or after L-NAME followed by NS-398. BP was 106 ± 4 mmHg and was unaffected by NS-398. L-NAME after NS-398 increased BP by 27 ± 2 mmHg, decreased RBF by one-half, and doubled renal vascular resistance (RVR; P < 0.001). Initial L-NAME increased BP by 26 ± 3 mmHg (P < 0.001) and decreased RBF by 44% (P < 0.001), doubling RVR. After L-NAME, NS-398 induced a further 7 ± 3-mmHg rise in BP (P < 0.05), decreased RBF by 20% (P < 0.025), and increased RVR by 23% (P < 0.01). The constrictor response to COX-2 inhibition after L-NAME could not be duplicated by either selective nNOS inhibition or NOS-independent renal vasoconstriction. Acute NOS inhibition unmasked renal vasoconstriction with COX-2 inhibition, suggesting that the influence of COX-2-derived vasodilator eicosanoids is exaggerated to maintain renal perfusion, compensating for the acute loss of NO.

renal blood flow; prostaglandins; neuronal nitric oxide synthase; endothelial nitric oxide synthase; renal vasoconstriction


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
M. E. Patterson, J. J. Mullins, and K. D. Mitchell
Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F205 - F211.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. B. Anning, B. Coles, J. Morton, H. Wang, J. Uddin, J. D. Morrow, S. K. Dey, L. J. Marnett, and V. B. O'Donnell
Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors
Blood, December 15, 2006; 108(13): 4059 - 4062.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Jerkic, J. V. Rivas-Elena, J. F. Santibanez, M. Prieto, A. Rodriguez-Barbero, F. Perez-Barriocanal, M. Pericacho, M. Arevalo, C. P.H. Vary, M. Letarte, et al.
Endoglin Regulates Cyclooxygenase-2 Expression and Activity
Circ. Res., August 4, 2006; 99(3): 248 - 256.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Ehmke and A. Kurtz
Deciphering the physiological roles of COX-2
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R486 - R487.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Lopez, M. T. Llinas, F. Roig, and F. J. Salazar
Role of nitric oxide and cyclooxygenase-2 in regulating the renal hemodynamic response to norepinephrine
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R488 - R493.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online